Storys aus Aachen-
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Fraunhofer-Institut für Produktionstechnologie IPT
Transforming personalized medicine with AI-driven CAR-T manufacturing: Automated CAR-T cell production platform is ready for production
mehrGrünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia
Aachen, Germany (ots) - - Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal's footprint in Latin America. - As part of the acquisition, Grünenthal will transfer the manufacturing of Cialis® to its production site in Chile. - Since 2017, ...
mehrMaren Thurow starts as new Head Global Communications at Grünenthal
mehrApotex licenses exclusive Canadian rights to Qutenza® from Grünenthal
Aachen, Germany & Toronto, Canada, (ots) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that they have entered into a strategic licensing agreement whereby Apotex will have the exclusive Canadian rights to Qutenza®, a topical, non-systemic, ...
mehrFEV develops AI-supported driver monitoring system CogniSafe
mehr
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
mehrFEV and ProLogium develop high-performance vehicle battery
mehrGrünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...
mehrFirst participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
mehrFraunhofer-Institut für Produktionstechnologie IPT
2Deep learning for real-time quality control: Aachen-based Fraunhofer Institutes improve defect detection in weld seams
mehrGrünenthal appoints Dr. Jan Adams as Chief Commercial Officer
mehr
Fraunhofer-Institut für Produktionstechnologie IPT
Life cycle assessment for energy-efficient and climate-friendly optics production
mehrGrünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®
Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...
mehr- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
mehr Fraunhofer-Institut für Produktionstechnologie IPT
5G Industry Campus Europe in Aachen expanded with Cloud RAN
mehrFraunhofer-Institut für Produktionstechnologie IPT
Hydrogen technologies at the Hannover Messe 2024: Fraunhofer IPT presents system designs for the production of bipolar plates, MEAs and pressure tanks
mehrFraunhofer-Institut für Produktionstechnologie IPT
Fraunhofer study report describes AI use cases and sustainable energy concepts
mehr
Fraunhofer-Institut für Produktionstechnologie IPT
Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems
mehrBehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...
mehrBehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...
mehrFraunhofer-Institut für Produktionstechnologie IPT
Fraunhofer IPT conducts research into automated series production of optics with new glass press
mehrGrünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration
Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...
mehrFraunhofer-Institut für Produktionstechnologie IPT
Fraunhofer study report on cybersecurity, digital twins and sustainability in production
mehr
Fraunhofer-Institut für Produktionstechnologie IPT
Joint expertise from industry and research: New regulations standardize optical coherence tomography
mehrFraunhofer-Institut für Produktionstechnologie IPT
Go-ahead for 6G in industry: EU funds technology development with more than 13 million euros
mehrFraunhofer-Institut für Produktionstechnologie IPT
Fraunhofer IPT manufactures super-lightweight frame for experiments in outer space
mehrHDI TH!NX makes battery reliability insurable on the basis of ACCURE battery analytics
mehrBVG Trials ACCURE’s Battery Safety Monitoring System on Electric Buses
mehrACCURE exceeds 1,111 megawatt-hours of monitored battery systems with battery-powered boats from Soel Yachts and Naval DC
mehr